15-41504848-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002344.6(LTK):c.2045G>A(p.Arg682Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,613,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002344.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTK | NM_002344.6 | c.2045G>A | p.Arg682Gln | missense_variant | 17/20 | ENST00000263800.11 | NP_002335.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTK | ENST00000263800.11 | c.2045G>A | p.Arg682Gln | missense_variant | 17/20 | 1 | NM_002344.6 | ENSP00000263800.6 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000232 AC: 58AN: 250320Hom.: 0 AF XY: 0.000207 AC XY: 28AN XY: 135314
GnomAD4 exome AF: 0.000145 AC: 212AN: 1460980Hom.: 0 Cov.: 33 AF XY: 0.000144 AC XY: 105AN XY: 726728
GnomAD4 genome AF: 0.000230 AC: 35AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.2045G>A (p.R682Q) alteration is located in exon 17 (coding exon 17) of the LTK gene. This alteration results from a G to A substitution at nucleotide position 2045, causing the arginine (R) at amino acid position 682 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at